The effector T-cell phenotype was equally prevalent in the circulation of the healthy individuals and rectal cancer patients but unsurprisingly with much higher cytotoxic activity (granzyme B and perforin expression, correlating with the WB-mtDNA TVN) in the patients. This evidence concerns the gene PRF1 and rectal cancer.